from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1862/adhA

LFCtreatmentdescriptionclass of inhibitor

-0.989

Amikacinug/mL Amikacintranslation

-0.438

Cap5-10ug/mL Capreomycintranslation

-0.620

Rox10-50 ug/mL Roxithromycintranslation

-1.160

SM2-5 ug/mL Streptomycintranslation

-0.282

Tet5-10 ug/mL Tetracyclinetranslation

1.030

Rif0.2-5ug/mL Rifampicintranscription

0.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.437

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.728

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.321

CPZ10-50 ug/mL Chlorpromazinerespiration

0.929

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.229

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.995

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.733

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.408

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.182

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.355

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.586

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.432

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.034

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.808

KCN5-20 ug/mL Potassium cyaniderespiration

0.532

NaN30.2-2 mM Sodium aziderespiration

-0.272

Nigericin50 uM Nigericinrespiration

0.657

TRC10-150 ug/mL Triclosanrespiration

1.960

TRZ10-25 ug/mL Thioridazinerespiration

-1.495

Valinomycin0.5-10 uM Valinomycinrespiration

-3.317

ZnSO42 mM ZnSO4respiration

0.339

menadione6-10 ug/mL Menadionerespiration

0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.396

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.456

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.900

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.406

NRP_1Non-replicating persistence stage 1dosRassociated

-0.878

Amp0.2mg/mL AmpicillincellWall

0.085

Cephalexin20-100 ug/mL CephalexincellWall

-0.964

Cerulenin0.32-5 ug/mL CerulenincellWall

0.412

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.057

EMB10-20 ug/mL EthambutolcellWall

-0.394

Eta12-40 ug/mL EthionamidecellWall

-0.867

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.449

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.229

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.039

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.074

BZA0.12 mg/mL BenzamidearomaticAmides

-0.061

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.430

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.205

H2O24 mM hydrogen peroxideDNAdamaging

-0.619

Levo10 ug/mL LevofloxacinDNAdamaging

-0.681

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.533

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.731

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.383

UVUV-irradiationDNAdamaging

1.370

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.358

Antimycin12.5-50 ug/mL Antimycin A?

-0.637

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.483

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.431

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.436

PA8240.2-2 ug/mL PA-824?

0.985

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.439

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.197

Verapamil50 uM Verapamil?

-0.250

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.672

methoxatin10-20 ug/mL Methoxatin?